BioSpace News Archive

John Krier Promoted to CEO Brian Baker Stepping Down for Personal Reasons, Continuing as Board Member and Consultant

Medidata, the global leader in creating end-to-end solutions to support the entire clinical trial process, and a Dassault Systèmes company, announced that CTI Clinical Trial and Consulting Services, a leading contract research organization, will use Medidata’s Remote Source Review to power remote monitoring and document review for multiple global studies, including several COVID-19 projects. This press release features multim

Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the TruSight™ Software Suite . TruSight Software delivers ready-made infrastructure to realize the full potential of whol

Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (OTCQB:SMTI), a provider of wound and skin care products dedicated to improving patient outcomes, announced today an update on the impact of the COVID-19 pandemic on the company’s financial results and operations.

Caligor Coghlan Pharma Services to Distribute Strontium89 (Strontium Chloride Injection Sr-89 USP) Outside the United States Agreement opens international markets ahead of schedule under Named Patient Program

Zing Health, a physician-led Medicare Advantage HMO plan, announced today Mete Sahin has been named Chief Financial Officer.

Progentec, a leader in next-gen diagnostics and digital technologies for the management of autoimmune diseases, announced today that it has entered into licensing agreements with Stanford University and the Oklahoma Medical Research Foundation to commercialize and sell laboratory technologies related to multiple sclerosis (MS).

Orpyx (orpyx.com), an innovator in digital health therapeutics to prevent diabetic foot complications, today announced the close of a $7.6M Series A investment round.

Asieris Pharmaceuticals (Asieris), a China -based biotech company with global aspirations to discover, develop and commercialize innovative drugs for the treatment of genitourinary tumors and related diseases, announced today it has received Clinical Trial Approval (CTA) from China’s National Medical Products Administration (NMPA) for th

Millennium Health conducted an analysis of over 500,000 definitive urine drug test (UDT) results for non-prescribed fentanyl, cocaine, heroin, and methamphetamine in the periods before and after COVID-19 was declared a national emergency.